Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Celsius Therapeutics operates in biotechnology, emergency medicine, genetics, health care, precision medicine based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2018.
The company sits in the biotechnology, emergency medicine, genetics, health care, precision medicine segment, where it competes on its core product or service.
Greater Boston Area, East Coast, New England, Northeastern US is where the company is located.
The company is listed at the Series_B stage of development.
The company reports a headcount in the c_00011_00050 range.
Public records show total funding of about $148M.
| Sector | Biotechnology, Emergency Medicine, Genetics, Health Care, Precision Medicine |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Country | United States |
| Founded | 2018 |
| Employees | c_00011_00050 |
| Stage | series_b |
| Total funding | $148,000,000 |
Website: www.celsiustx.com
Browse related
Create a free account